STAAR Surgical Q1 2026: Early Signs Of A Durable Turnaround
STAAR Surgical Company delivered a robust 1Q26 beat, with revenue up 119% YoY to $93.5M and a swing…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Trend
+11.0% vs SMA 50 · +24.9% vs SMA 200
Momentum
Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $87.3M $86.6M–$88.5M | — | $0.87 | — | ±1% | Low1 |
FY2024 | $129.5M $128.3M–$130.6M | ▲ +48.2% | $0.97 | ▲ +10.5% | ±34% | Low2 |
FY2025 | $179.1M $178.2M–$179.6M | ▲ +38.3% | $1.85 | ▲ +91.0% | ±1% | Moderate3 |
Dividend per payment — last 2 periods
STAAR Surgical Company delivered a robust 1Q26 beat, with revenue up 119% YoY to $93.5M and a swing…

No description available.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
BCAL◀ | $18.60 | +0.22% | $598M | 10.1 | — | 2706.4% | 1500 |
| $297.81 | -0.70% | $798.0B | 14.1 | +330.7% | 2039.3% | 1503 | |
| $325.75 | +1.00% | $624.4B | 28.0 | +1134.0% | 5014.5% | 1500 | |
| $494.20 | +0.87% | $436.7B | 28.3 | +1641.6% | 4564.7% | 1490 | |
| $49.77 | -0.16% | $353.2B | 11.4 | -45.1% | 1592.6% | 1495 | |
| $192.51 | -1.04% | $303.6B | 16.6 | +1147.7% | 1466.4% | 1526 | |
| $948.47 | -2.11% | $279.8B | 15.9 | -138.4% | 1373.0% | 1526 | |
| Sector avg | — | -0.28% | — | 17.8 | +678.4% | 2679.6% | 1506 |